TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23340248

Group type: COMPARATOR
Intervention: 0 g polydextrose (control)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 6.3 g polydextrose
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 12.5 g polydextrose
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 25 g polydextrose
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control preload
Number of subjects: 21
Study: 21079110

Group type: EXPERIMENTAL
Intervention: Extended arm (evidence-based practice bundle including omission of mechanical bowel preparation, preoperative and intraoperative warming, supplemental oxygen, intraoperative intravenous fluid restriction, use of a surgical wound protector)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Standard arm (current practice)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Extended arm
Number of subjects: 197

Group type: COMPARATOR
Intervention: Standard arm
Number of subjects: 197
Study: 19936217

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DHA-PQP)
Number of subjects: 1553

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 1553
Study: 17680178

Group type: EXPERIMENTAL
Intervention: Heparin anticoagulation at 180 U x kg(‐1) plus 3000 U every 30 min for OPCAB patients, along with rectal aspirin 650 mg during the procedure.
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Heparin anticoagulation regimen in OPCAB patients.
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Heparin and protamine doses in OPCAB group.
Number of subjects: 197

Group type: COMPARATOR
Intervention: OPCAB group outcomes.
Number of subjects: 197
Study: 14986215

Group type: EXPERIMENTAL
Intervention: Audiovisual distraction and patient-controlled sedation (PCS)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Visual distraction and patient-controlled sedation (PCS)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Patient-controlled sedation (PCS) alone
Number of subjects: 165
Study: 11461729

Group type: EXPERIMENTAL
Intervention: 4 French catheters
Number of subjects: 400

Group type: COMPARATOR
Intervention: 6 French catheters
Number of subjects: 400
Study: 10806855

Group type: EXPERIMENTAL
Intervention: Subcutaneous rhEpo 150 U/kg.time, three times a week for 6 weeks
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Subcutaneous rhEpo 250 U/kg.time, three times a week for 6 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 45
Study: 7778529

Group type: EXPERIMENTAL
Intervention: Delapril 30 mg twice daily
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Delapril 15 mg twice daily
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 2306782

Group type: EXPERIMENTAL
Intervention: 5F catheters
Number of subjects: 52

Group type: COMPARATOR
Intervention: 7/8F catheters
Number of subjects: 52
Study: 312976

Group type: EXPERIMENTAL
Intervention: Solu‐Medrol (methylprednisolone sodium succinate) 1 g/liter
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no steroid treatment)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Solu‐Medrol (methylprednisolone sodium succinate)
Number of subjects: 20
Study: 31573835

Group type: EXPERIMENTAL
Intervention: CMM+KneeKG
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: CMM+KneeKG+Education
Number of subjects: 515

Group type: COMPARATOR
Intervention: CMM
Number of subjects: 515
Study: 31748254

Group type: EXPERIMENTAL
Intervention: Prenatal and infant home nurse visit (NV)
Number of subjects: 742

Group type: COMPARATOR
Intervention: Control (free transportation for prenatal care plus child development screening and referral)
Number of subjects: 742
Study: 28134057

Group type: EXPERIMENTAL
Intervention: RAL + LPV/r
Number of subjects: 50

Group type: COMPARATOR
Intervention: EFV/TDF/FTC
Number of subjects: 50
Study: 25887067

Group type: EXPERIMENTAL
Intervention: Cinacalcet
Number of subjects: 3861

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3861
Study: 24583364

Group type: EXPERIMENTAL
Intervention: Percutaneous endoscopic lumbar discectomy (PELD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional open lumbar discectomy (OD)
Number of subjects: 0
Study: 24333889

Group type: EXPERIMENTAL
Intervention: Three months of drug therapy for comorbid mental disorders
Number of subjects: 55
Study: 19631848

Group type: EXPERIMENTAL
Intervention: Local anesthetics
Number of subjects: 0
Study: 17474852

Group type: EXPERIMENTAL
Intervention: Active navigation
Number of subjects: 54

Group type: COMPARATOR
Intervention: Passive navigation
Number of subjects: 54
Study: 15059786

Group type: EXPERIMENTAL
Intervention: Patients with idiopathic hyperventilation (IH)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 39
Study: 11851661

Group type: EXPERIMENTAL
Intervention: Tensopress bandages
Number of subjects: 112

Group type: COMPARATOR
Intervention: Elastocrepe bandages
Number of subjects: 112
Study: 10401950

Group type: EXPERIMENTAL
Intervention: CHDF circuit with a haemofilter made of polymethylmethacrylate membrane primed with 50 mg nafamostat in 500 ml saline, continuous injection of 0.5 mg/kg per h nafamostat, 700 ml/h of dialysis fluid and 1000 ml/h of filtrate fluid
Number of subjects: 10
Study: 7641525

Group type: EXPERIMENTAL
Intervention: Cataphoric devices (spoken stress and the indefinite this)
Number of subjects: 0
Study: 2620043

Group type: EXPERIMENTAL
Intervention: Mebeverine (135 mg, two capsules, three times daily)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Mefenamic acid (250 mg, two capsules, three times daily)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo (two capsules, three times daily)
Number of subjects: 64
Study: 1091532

Group type: EXPERIMENTAL
Intervention: Wheat bran (20 g daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ground oatflakes (equal volume)
Number of subjects: 20
Study: 31021882

Group type: EXPERIMENTAL
Intervention: Serratus plane block (SPB) with 25 ml of ropivacaine 0.5%
Number of subjects: 72

Group type: COMPARATOR
Intervention: Physiological saline (control)
Number of subjects: 72
Study: 28276061

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral pain self‐management (CBPSM) protocol delivered by physical therapists (PTs)
Number of subjects: 588

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 588
Study: 25478975

Group type: EXPERIMENTAL
Intervention: Remifentanil (0.75 μg/kg over 30 seconds)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Ketamine (0.25 mg/kg over 30 seconds)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Propofol (0.5 mg/kg over 30 seconds)
Number of subjects: 54
Study: 23228271

Group type: EXPERIMENTAL
Intervention: GuttaCore
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Warm vertical
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Thermafil Plus
Number of subjects: 60
Study: 21516005

Group type: EXPERIMENTAL
Intervention: Self-foot reflexology (1 hr/session, 3 times a week for 6 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 60
Study: 19483370

Group type: EXPERIMENTAL
Intervention: Vegetable tablets (10 g/trial)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control tablets (10 g/trial)
Number of subjects: 7
Study: 16512765

Group type: COMPARATOR
Intervention: Control group (CG) - quadrant root planing at 1-week intervals over four consecutive sessions
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Periodontal debridement plus povidone-iodine group (PD-PIG) - 45-minute full-mouth debridement with ultrasonic instrument and 0.5% povidone-iodine irrigation
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Periodontal debridement group (PDG) - 45-minute full-mouth debridement with ultrasonic instrument and NaCl irrigation
Number of subjects: 45
Study: 15330904

Group type: EXPERIMENTAL
Intervention: Sedation
Number of subjects: 419

Group type: COMPARATOR
Intervention: Placebo (no sedation)
Number of subjects: 419
Study: 11761819

Group type: EXPERIMENTAL
Intervention: Inhaled ambroxol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 9099565

Group type: EXPERIMENTAL
Intervention: Balanced comfort levels (C)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Unbalanced comfort levels (C)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Unbalanced comfort levels (C) with halved unbalancing
Number of subjects: 10

Group type: COMPARATOR
Intervention: Unbalanced comfort levels (C) with doubled unbalancing
Number of subjects: 10

Group type: COMPARATOR
Intervention: 20% unbalancing
Number of subjects: 10
Study: 8131253

Group type: EXPERIMENTAL
Intervention: 15 mg/kg mefloquine
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 25 mg/kg mefloquine
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Quinine (30 mg.kg‐1.day‐1) + Tetracycline (25 mg.kg‐1.day‐1) for re-treatment
Number of subjects: 110
Study: 2481671

Group type: EXPERIMENTAL
Intervention: Chemotherapy (specific agents not detailed)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-agent regimens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New approaches to management
Number of subjects: 0
Study: 31351696

Group type: EXPERIMENTAL
Intervention: 2-view radiograph series (AP pelvis and Dunn hip)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5-view radiograph series (AP pelvis, AP, 45° Dunn, frog lateral, false profile)
Number of subjects: 0
Study: 31707838

Group type: EXPERIMENTAL
Intervention: Physicians' recommendation for surgery
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Physicians' recommendation for physiotherapy
Number of subjects: 194

Group type: COMPARATOR
Intervention: No recommendation
Number of subjects: 194
Study: 31648764

Group type: EXPERIMENTAL
Intervention: iFR-guided strategy
Number of subjects: 2492

Group type: COMPARATOR
Intervention: FFR-guided strategy
Number of subjects: 2492

Group type: EXPERIMENTAL
Intervention: Mean FFR value
Number of subjects: 2492

Group type: EXPERIMENTAL
Intervention: Mean iFR value
Number of subjects: 2492
Study: 29046732

Group type: EXPERIMENTAL
Intervention: Group 1 (G1): 300 g of vegetables and legumes containing on average 191 μg/day of folate and 1 hazelnut oil capsule
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group 2 (G2): 300 g of vegetables and legumes containing on average 191 μg/day of folate and 1 placebo capsule
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Group 3 (G3): 300 g of vegetables and legumes containing on average 90 μg/day of folate and 1 hazelnut oil capsule
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group 4 (G4): Follow-up with regular dietary habits
Number of subjects: 40
Study: 27097492

Group type: EXPERIMENTAL
Intervention: Perfusion of low molecular dextran via the splenic artery
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (extensive devascularization around the cardia)
Number of subjects: 92
Study: 25305223

Group type: EXPERIMENTAL
Intervention: Riboflavin supplementation (10 mg/day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 22094154

Group type: EXPERIMENTAL
Intervention: Metal-on-metal bearing
Number of subjects: 80

Group type: COMPARATOR
Intervention: Ceramic-on-ceramic bearing
Number of subjects: 80
Study: 19689091

Group type: EXPERIMENTAL
Intervention: Positive deviance approach (PD Micah)
Number of subjects: 371

Group type: COMPARATOR
Intervention: Micah (control group)
Number of subjects: 371
Study: 16797805

Group type: EXPERIMENTAL
Intervention: rPA102 5 microg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: rPA102 25 microg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: rPA102 50 microg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: rPA102 75 microg
Number of subjects: 100

Group type: COMPARATOR
Intervention: AVA
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: rPA102 5 microg (after 3rd vaccination)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: rPA102 25 microg (after 3rd vaccination)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: rPA102 50 microg (after 3rd vaccination)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: rPA102 75 microg (after 3rd vaccination)
Number of subjects: 100
Study: 12622768

Group type: EXPERIMENTAL
Intervention: Wheat-starch-based gluten-free diet
Number of subjects: 57

Group type: COMPARATOR
Intervention: Natural gluten-free diet
Number of subjects: 57
Study: 10660924

Group type: EXPERIMENTAL
Intervention: Foot reflexology (30 minutes total by a certified reflexologist)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Foot reflexology
Number of subjects: 23
Study: 9291263

Group type: EXPERIMENTAL
Intervention: Mandibular overdenture supported by two implants with ball attachments
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Two implants with an interconnecting bar
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Four interconnected implants
Number of subjects: 110
Study: 8346830

Group type: COMPARATOR
Intervention: Intravenous lidocaine (0.5, 1.0, 1.5, or 2.0 mg/kg)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Intravenous lidocaine (2 mg/kg)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study: 2953734

Group type: EXPERIMENTAL
Intervention: Ioxaglate (Hexabrix)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sodium-meglumine diatrizoate (Renografin-76)
Number of subjects: 60
Study: 31620802

Group type: EXPERIMENTAL
Intervention: 80 mg ixekizumab every 2 weeks for 12 weeks, then 80 mg open-label ixekizumab every 4 weeks through Week 52
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for 12 weeks, then 80 mg open-label ixekizumab every 4 weeks through Week 52
Number of subjects: 0
Study: 30041702

Group type: EXPERIMENTAL
Intervention: Single intravenous dose of co-amoxiclav
Number of subjects: 3424

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3424
Study: 28522085

Group type: EXPERIMENTAL
Intervention: Modified uvulopalatopharyngoplasty (UPPP)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (delayed surgery)
Number of subjects: 65
Study: 26265075

Group type: EXPERIMENTAL
Intervention: Elastic Resistance Training (ERT) twice a week for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group (no intervention)
Number of subjects: 40
Study: 23294528

Group type: EXPERIMENTAL
Intervention: Serum YKL-40
Number of subjects: 4372
Study: 21410627

Group type: EXPERIMENTAL
Intervention: sitagliptin/metformin FDC 50/500 mg bid
Number of subjects: 1250

Group type: COMPARATOR
Intervention: metformin monotherapy 500 mg bid (uptitrated to 1000 mg bid)
Number of subjects: 1250

Group type: EXPERIMENTAL
Intervention: sitagliptin/metformin FDC
Number of subjects: 1250

Group type: COMPARATOR
Intervention: metformin monotherapy
Number of subjects: 1250
Study: 18242449

Group type: EXPERIMENTAL
Intervention: Viscoat (sodium chondroitin sulfate 4%-sodium hyaluronate 3%)
Number of subjects: 30

Group type: COMPARATOR
Intervention: DuoVisc (Viscoat and Provisc [sodium hyaluronate 1%])
Number of subjects: 30
Study: 16532455

Group type: EXPERIMENTAL
Intervention: Gabapentin treatment (600-2,700 mg/day)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Gabapentin treatment
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 14612979

Group type: EXPERIMENTAL
Intervention: 15 mg beta-carotene or lycopene supplementation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 30 mg beta-carotene or lycopene supplementation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10843171

Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg/day
Number of subjects: 543

Group type: EXPERIMENTAL
Intervention: Risedronate 2.5 mg/day
Number of subjects: 543

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 543
Study: 8869876

Group type: EXPERIMENTAL
Intervention: Oestrogen replacement therapy
Number of subjects: 875

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 875
Study: 1346817

Group type: COMPARATOR
Intervention: Standard heparin (to achieve an activated partial thromboplastin time of 1.5 to 2.0 times the pretreatment value)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (adjusted only for body weight) for 10 days
Number of subjects: 170

Group type: COMPARATOR
Intervention: Standard heparin
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin
Number of subjects: 170
Study: 6845106

Group type: EXPERIMENTAL
Intervention: Calcitonin 5.0 micrograms/h
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Calcitonin 2.5 micrograms/h
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 9
Study: 31761744

Group type: EXPERIMENTAL
Intervention: Telephone information (experimental group)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Face-to-face information (control group)
Number of subjects: 160
Study: 30275142

Group type: EXPERIMENTAL
Intervention: ICDAS e‐learning (G1, n=21)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: ICDAS e‐learning + digital learning tool (DLT) (G2, n=22)
Number of subjects: 64

Group type: COMPARATOR
Intervention: No training (control group, G3, n=21)
Number of subjects: 64
Study: 27553712

Group type: EXPERIMENTAL
Intervention: Oxytocin (24 IU) administered intranasally
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 24471659

Group type: COMPARATOR
Intervention: Placebo (group C)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Intravenous parecoxib 40 mg then oral celecoxib 400 mg at 12 hours (group PC)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol 2 g then oral 1 g six-hourly (group PA)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Combination of intravenous parecoxib, oral celecoxib, and paracetamol (group PCPA)
Number of subjects: 111
Study: 22752297

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate (AA) 1,000 mg orally once daily + prednisone 5 mg orally twice daily
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate (AA)
Number of subjects: 33
Study: 19056215

Group type: COMPARATOR
Intervention: No drainage
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Drainage for 24 hours
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Drainage for 48 hours
Number of subjects: 139
Study: 17676319

Group type: EXPERIMENTAL
Intervention: Voriconazole 400 mg twice daily on the first day and 200 mg twice daily on the second day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fluconazole 400 mg on the first day and 200 mg on the second day
Number of subjects: 12
Study: 16231818

Group type: EXPERIMENTAL
Intervention: Early laparoscopy (260 patients)
Number of subjects: 522

Group type: COMPARATOR
Intervention: Active observation (262 patients)
Number of subjects: 522
Study: 12135535

Group type: EXPERIMENTAL
Intervention: 75 mg/d venlafaxine
Number of subjects: 146

Group type: COMPARATOR
Intervention: 20 mg/d fluoxetine
Number of subjects: 146
Study: 10197842

Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg
Number of subjects: 297
Study: 8845580

Group type: EXPERIMENTAL
Intervention: Feminine-relevant cold-pressor test
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Masculine-relevant cold-pressor test
Number of subjects: 121
Study: 2332919

Group type: EXPERIMENTAL
Intervention: Diltiazem hydrochloride (360 mg daily)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Propranolol hydrochloride (240 mg daily)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 6774359

Group type: EXPERIMENTAL
Intervention: Thyrotropin-releasing hormone (TRH), 0.5 mg i.v.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Thyroid hormones (TH) pretreatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Thyrotropin-releasing hormone (TRH) with TH pretreatment
Number of subjects: 20
Study: 31405122

Group type: EXPERIMENTAL
Intervention: Lactobacillus gasseri CP2305 tablets
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 60
Study: 28625442

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.6μg·kg‐1) followed by 0.2μg·kg‐1·h‐1 until the end of operation
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 72
Study: 25888548

Group type: EXPERIMENTAL
Intervention: 65Gy boost + chemoradiation (sCRT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: 50Gy standard chemoradiation (sCRT)
Number of subjects: 120
Study: 23648611

Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham stimulation (placebo group)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 46
Study: 20727237

Group type: COMPARATOR
Intervention: Fibre supplement (psyllium)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Healthy eating plus fibre supplement (HLT-FIB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Healthy eating (HLT)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Control (placebo)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Fibre supplement (FIB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Healthy eating plus placebo (HLT)
Number of subjects: 100
Study: 19952360

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) treatment in men
Number of subjects: 1192

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) treatment in women
Number of subjects: 1192
Study: 17161934

Group type: EXPERIMENTAL
Intervention: Preadmission education using the concept map method with written educational material (Group A)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Standard preadmission education (written educational material with non-systematic oral education) (Group B)
Number of subjects: 123
Study: 14984434

Group type: EXPERIMENTAL
Intervention: Pravastatin treatment
Number of subjects: 674

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 674
Study: 11157645

Group type: EXPERIMENTAL
Intervention: Low-intensity oral anticoagulant therapy (targeted INR of 2.5; range, 2.0 to 3.0)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower-intensity regimens (INR < 2.0)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IV heparin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heparin dosage and age (> 70 years)
Number of subjects: 0

Group type: COMPARATOR
Intervention: LMW heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard heparin
Number of subjects: 0